May 6, 2025
[Brussels, Belgium] — Kidney Disease: Improving Global Outcomes (KDIGO) is pleased to announce Christoph Wanner, MD, as its new Co-Chair Elect.
Dr. Wanner was elected by the KDIGO Executive Committee and will join Morgan Grams, MD (NYU Langone Health, United States) as Co-Chair of KDIGO. He will succeed Michel Jadoul, MD (Cliniques Universitaires Saint-Luc, UCLouvain, Belgium), who has served in this volunteer role since 2019 and will conclude his term at the end of December 2025. Dr. Wanner will begin his term on January 1, 2026. KDIGO Co-Chairs are the foundation’s top leaders, guiding organizational strategy, setting priorities, overseeing programs, and ensuring the quality, relevance, and clinical utility of KDIGO’s scientific work.
Dr. Wanner is a senior professor of medicine in the Department of Clinical Studies and Epidemiology at the University Hospital of Würzburg, Germany, and a visiting professor of nephrology at the University of Oxford, United Kingdom. An internationally recognized nephrologist, Dr. Wanner has made significant contributions to diabetic kidney disease, cardiovascular risk in dialysis, lipid disorders, and rare kidney conditions. He is the immediate-past president of the European Renal Association and played leading roles in landmark clinical trials, including the 4D Study, SHARP, and EMPA-KIDNEY.
A long-time KDIGO volunteer, Dr. Wanner has held numerous roles within the organization. He has served as a KDIGO Executive Committee member, co-chaired the KDIGO Lipids in CKD Guideline, participated as a Work Group member on the KDIGO 2020 and 2022 Diabetes Guidelines, and contributed to a wide range of KDIGO programs, including Controversies Conferences, Implementation Summits, and educational activities.
“KDIGO is a respected global leader in developing trusted, evidence-based guidance that shapes kidney care around the world,” said Dr. Wanner. “I’m honored to serve as KDIGO Co-Chair and to support its mission to improve outcomes for people with kidney disease through international collaboration, clinical excellence, and meaningful implementation.”
“KDIGO is a respected global leader in developing trusted, evidence-based guidance that shapes kidney care around the world,” said Dr. Wanner. “I’m honored to serve as KDIGO Co-Chair and to support its mission to improve outcomes for people with kidney disease through international collaboration, clinical excellence, and meaningful implementation.”
“I am absolutely delighted that Christoph Wanner will be joining me as KDIGO Co-Chair,” said Dr. Grams. “Christoph brings unmatched insight, clinical expertise, and intellectual rigor to everything he does. He’s also an exceptionally thoughtful and generous collaborator. KDIGO is extremely fortunate to have his leadership in this role.”
“KDIGO could not have chosen a better person for this role,” said Dr. Jadoul. “Christoph is brilliant, highly respected in the field, and deeply committed to KDIGO’s mission. I have worked with him for many years and know he will bring outstanding leadership to the organization. KDIGO is in excellent hands.”
“KDIGO could not have chosen a better person for this role,” said Dr. Jadoul. “Christoph is brilliant, highly respected in the field, and deeply committed to KDIGO’s mission. I have worked with him for many years and know he will bring outstanding leadership to the organization. KDIGO is in excellent hands.”
For more information, please contact [email protected].
